| Autor: |
Gelinas DS; Centre for Research in Neurodegenerative Diseases and Department of Laboratory Medicine and Pathobiology, University of Toronto, Tanz Neuroscience Building, 6 Queen's Park Crescent West, Toronto, Ontario, M5S3H2, Canada. david.gelinas@utoronto.ca, McLaurin J |
| Jazyk: |
angličtina |
| Zdroj: |
Neurochemical research [Neurochem Res] 2005 Nov; Vol. 30 (11), pp. 1369-75. |
| DOI: |
10.1007/s11064-005-8341-y |
| Abstrakt: |
Dehydroepiandrosterone (DHEAS) was given the name "fountain of youth" in reference to its beneficial properties in memory, cognition and aging. Cultured cell studies showed that DHEAS may mediate its action by counteracting aging-associated inflammation via PPAR-alpha activation. In the present study, we demonstrated an age-dependent increase in IL-1beta and TNF-alpha expression in the brain and the spleen of aging rats, while PPAR-alpha expression was decreased in the spleen of 18 month-old rats. Oral treatment with DHEAS increased PPAR-alpha mRNA in 3 month-old rats and decreased PPAR-alpha protein expression in 18 month-old rats in the spleen. In contrast, DHEAS did not alter cytokine expression in spleen and brain of the three age groups. These findings underline a differential role for DHEAS in PPAR-alpha expression that is age-dependent, and also, that beneficial effects of DHEAS on cognitive function are unlikely mediated by a decrease in cytokine expression. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink